MedPath

Lidocaine and Prilocaine

Lidocaine and Prilocaine Cream, USP 2.5%/2.5%

Approved
Approval ID

d3380195-2f0c-4afd-9500-9e265429f67e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 12, 2022

Manufacturers
FDA

Aleor Dermaceuticals Limited

DUNS: 871411532

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine and Prilocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71589-017
Application NumberANDA213923
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine and Prilocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 12, 2022
FDA Product Classification

INGREDIENTS (6)

LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PEG-54 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: HHT01ZNK31
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine and Prilocaine - FDA Drug Approval Details